Departmental Hospital at Smolensk Station RZhD JSC

Smolensk 214025

0 studies enrolling now · 7 studies all time

What they study most

Ankylosing Spondyloarthritis, Lupus Erythematosus, Systemic, Psoriatic Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis — Completed
• Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed